Allstate Corporation’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,487
Closed -$3.63M 550
2025
Q1
$3.63M Sell
7,487
-128
-2% -$62.1K 0.11% 119
2024
Q4
$3.07M Buy
+7,615
New +$3.07M 0.09% 125
2024
Q3
Sell
-906
Closed -$425K 223
2024
Q2
$425K Sell
906
-19
-2% -$8.91K 0.03% 136
2024
Q1
$387K Sell
925
-6
-0.6% -$2.51K 0.03% 141
2023
Q4
$379K Sell
931
-58
-6% -$23.6K 0.03% 132
2023
Q3
$344K Hold
989
0.02% 140
2023
Q2
$348K Buy
989
+6
+0.6% +$2.11K 0.02% 144
2023
Q1
$310K Sell
983
-11,653
-92% -$3.67M 0.02% 147
2022
Q4
$3.65M Hold
12,636
0.11% 128
2022
Q3
$3.66M Hold
12,636
0.11% 118
2022
Q2
$3.56M Sell
12,636
-6,238
-33% -$1.76M 0.11% 120
2022
Q1
$4.93M Sell
18,874
-208
-1% -$54.3K 0.13% 114
2021
Q4
$4.19M Buy
19,082
+12,315
+182% +$2.7M 0.08% 194
2021
Q3
$1.23M Sell
6,767
-387
-5% -$70.2K 0.05% 243
2021
Q2
$1.44M Sell
7,154
-1,392
-16% -$281K 0.05% 211
2021
Q1
$1.84M Buy
8,546
+2,111
+33% +$454K 0.06% 174
2020
Q4
$1.52M Sell
6,435
-1,368
-18% -$323K 0.05% 192
2020
Q3
$2.12M Sell
7,803
-1,715
-18% -$467K 0.07% 88
2020
Q2
$2.76M Buy
9,518
+257
+3% +$74.6K 0.09% 81
2020
Q1
$2.2M Sell
9,261
-21,700
-70% -$5.16M 0.09% 97
2019
Q4
$6.78M Buy
30,961
+174
+0.6% +$38.1K 0.12% 94
2019
Q3
$5.22M Buy
30,787
+1,961
+7% +$332K 0.09% 129
2019
Q2
$5.29M Buy
28,826
+3,863
+15% +$708K 0.09% 119
2019
Q1
$4.59M Hold
24,963
0.12% 116
2018
Q4
$4.14M Buy
+24,963
New +$4.14M 0.14% 113